Tributyrin

Tributyrin, or glyceryl tributyrate, is a triester of glycerol in which each of the three hydroxyl groups is bound to a molecule of butyric acid. It is a naturally occurring fat found in dairy, with butter being its richest food source, and appears as an oily, water-insoluble liquid with a bitter taste. Chemically it belongs to the short-chain triglycerides, and on hydrolysis it yields glycerol and free butyrate.

The compound's main interest lies in its role as a prodrug for butyric acid. Butyrate itself is poorly suited to oral dosing because it is cleared quickly and unpleasant to take, whereas tributyrin is stable, well absorbed and able to raise circulating butyrate for a period of hours after ingestion ^[1]. Early clinical pharmacology confirmed that oral tributyrin produces measurable plasma butyrate, though levels are short-lived and vary between individuals, which led investigators to explore divided daily dosing ^[1][2].

Much of the research on tributyrin follows from the biology of butyrate. As a short-chain fatty acid, butyrate inhibits histone deacetylase enzymes, an action that alters gene expression and can drive cell differentiation; tributyrin has been shown to reshape the epigenetic landscape of muscle stem cells in line with this mechanism ^[4]. It was tested in Phase I oncology trials in the late 1990s and early 2000s as a differentiation agent for solid tumors ^[1][2], and more recent work has examined butyrate and tributyrin in gut health, metabolism and sleep, where oral tributyrin increased slow-wave sleep in rodents by way of a signal sensed in the liver or portal vein ^[3]. In the microbiology laboratory, tributyrin hydrolysis is used as a test that helps identify the bacterium Moraxella catarrhalis.

Tributyrin is not an approved drug; it is sold over the counter as a dietary supplement, often described as a postbiotic and marketed under trade names such as CoreBiome and ButyraGen. As a food-derived substance it is also encountered as a flavoring ingredient.

Because it delivers butyrate rather than acting through a novel pharmacology, its tolerability broadly reflects that of butyrate; clinical studies in cancer patients reported gastrointestinal effects such as nausea and cramping among the more common complaints, without dose-limiting toxicity at the levels tested ^[1][2].

Tributyrin is a butyrate prodrug, a glyceride that releases butyric acid, and as a food-derived compound it is generally well tolerated, with gastrointestinal upset such as nausea or loose stools the most likely complaint. Human data for supplemental use are limited, so long-term safety at supplement doses is not well established. People with gastrointestinal disease or on other therapies should be cautious given the sparse evidence.

Tributyrin, also called glyceryl tributyrate, is a natural triglyceride in which glycerol is esterified with three molecules of butyric acid, and it occurs in ordinary foods, most familiarly as a component of butter that contributes to its characteristic aroma. Its emergence as a compound of therapeutic interest owes less to a single discovery than to a practical problem: butyrate, a short-chain fatty acid with intriguing biological effects, is difficult to deliver because butyrate salts are cleared rapidly and can be unpalatable.

Investigators recognized that tributyrin, being lipophilic and orally absorbable, could act as a prodrug that releases butyrate more efficiently and durably once broken down by the body's lipases. This rationale led to its evaluation as an anticancer differentiation agent, including early-phase clinical studies in the 1990s that explored its ability to inhibit histone deacetylase enzymes. In more recent years it has been reframed as a postbiotic dietary supplement and studied for gut health, muscle biology, and, in early research, sleep and mood, reflecting the broad reach of butyrate signaling.

Tributyrin has built an appealing reputation in the gut-health and longevity communities as an elegant way to deliver butyrate, the short-chain fatty acid that colon cells use as their preferred fuel. Its central advantage is practical; as a stable, fat-soluble prodrug it carries butyrate further and more comfortably than butyrate salts, avoiding much of the rapid clearance and odor that limit those alternatives.

Supporters point to butyrate's well-documented roles in nourishing the intestinal lining, supporting the gut barrier, and acting as a histone deacetylase inhibitor that can dial down inflammatory signaling. It is worth being clear that much of the most striking evidence comes from laboratory and animal work, and that human clinical data, while growing and now extending into areas such as mood, remain at an early stage. For those interested in supporting gut health through the microbiome's own chemistry, however, tributyrin offers a scientifically grounded and thoughtfully designed approach.